Osteopenia Clinical Trial
Official title:
Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia. A Randomized, Placebo-controlled, Double Blind Investigation.
The purpose of this study is to investigate whether the use of alkali compounds, i.e.
potassium citrate (K3C6H5O7, hereinafter KCitr) is effective in preventing the progression of
osteopenia.
A randomized clinical trial (RCT, placebo-controlled, double-blind) has been planned to
evaluate the effect of the daily administration of KCitr (3 g/die, K 30 mEq).
The efficacy will be evaluated by comparing the circulating levels of bone turnover markers
at the baseline and after the treatment (3, 6 months).
Bone tissue carries out some of the important metabolic functions, including the regulation
of acid-base balance. In order to buffer the systemic acidosis, the skeleton acts as a "ion
exchange column" modifying the composition of the mineral portion, i.e. the hydroxyapatite.
There is a linear correlation between elimination of calcium and acidosis: the higher is the
acidosis, the higher will be the loss of calcium from bones. In vitro experiments showed that
acidosis also directly influences the cellular component of bone by increasing the osteoclast
activity and inhibiting the production of the mineralized matrix by osteoblast. Since the low
pH is a risk factor that accelerates the bone loss, the use of alkalizing compounds could
prevent the osteopenia or support the conventional therapy of the osteoporosis.
KCitr is an alkaline compound which may be used in metabolic acidosis. Potassium is an
alkaline metal that plays a pivotal role in the function of all living cells. Citric acid is
a key molecule of the Krebs cycle, and it is abundant in bone where exhibits a stabilizing
function. Although clinical data regarding the KCitr effectiveness on calcium metabolism are
encouraging, it is still unclear whether the beneficial effects are due exclusively to the
buffering function or whether KCitr may affect the bone cells activity. The purpose of this
study is to evaluate the effects of KCitr on bone metabolism. We hypothesize that
administration of potassium citrate to postmenopausal women with osteopenia will delay (or
will prevent) the weakening of bone mass.
Postmenopausal women with osteopenia (T score between -1.0 and -2.5) and no history of
fracture will be randomized to assume KCitr ate or placebo, daily for six months. Primary
outcomes will be evaluated by measuring markers of bone turnover, which will be measured at
baseline (before treatment), in the mid-term (3 months) and at the end (6 months).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Active, not recruiting |
NCT05066477 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women
|
N/A | |
Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
Completed |
NCT01439139 -
Bone UltraSonic Scanner (BUSS): Validation Study
|
N/A | |
Not yet recruiting |
NCT01397838 -
Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women
|
Phase 1 | |
Completed |
NCT01222026 -
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
|
Phase 4 | |
Completed |
NCT01152580 -
Melatonin Osteoporosis Prevention Study
|
Phase 1 | |
Completed |
NCT00789425 -
Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women
|
Phase 2 | |
Completed |
NCT00463268 -
Osteoporosis Prevention With Low Dose Alendronate
|
Phase 3 | |
Completed |
NCT00655681 -
Prevention of Post Operative Bone Loss in Children
|
N/A | |
Completed |
NCT00798473 -
Zoledronate for Osteopenia in Pediatric Crohn's
|
Phase 3 | |
Active, not recruiting |
NCT00076050 -
Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms
|
Phase 3 | |
Completed |
NCT00226031 -
Optimal Management of Women With Wrist Fractures
|
N/A | |
Enrolling by invitation |
NCT04752098 -
A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method
|
N/A | |
Completed |
NCT04720833 -
Effect of Dried Plum on Bone and Markers of Bone Status in Men
|
N/A | |
Recruiting |
NCT05541432 -
Finding the Optimal Resistance Training Intensity For Your Bones
|
N/A | |
Active, not recruiting |
NCT05405894 -
Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
|
||
Completed |
NCT05457036 -
Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile
|
N/A | |
Completed |
NCT04040010 -
The Effects of Bovine Colostrum in Bone Metabolism in Humans
|
N/A | |
Completed |
NCT05721014 -
Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health
|
N/A |